ACTIVE INGREDIENT
ACTIVE INGREDIENTS: TITANIUM DIOXIDE (CI 77891) (6.20%), ETHYLHEXYL METHOXYCINNAMATE (5.00%), ZINC OXIDE (CI 77947) (2.94%)
ACTIVE INGREDIENTS: TITANIUM DIOXIDE (CI 77891) (6.20%), ETHYLHEXYL METHOXYCINNAMATE (5.00%), ZINC OXIDE (CI 77947) (2.94%)
INACTIVE INGREDIENTS: TALC,MICA(CI 77019),METHYL METHACRYLATE CROSSPOLYMER,NYLON-12,SILICA,HDI/TRIMETHYLOL HEXYLLACTONE CROSSPOLYMER,BARIUM SULFATE,ETHYLENE/ACRYLIC ACID COPOLYMER,DIISOSTEARYL MALATE,TRIMETHYLOLPROPANE TRIETHYLHEXANOATE,CAPRYLIC/CAPRIC TRIGLYCERIDE,IRON OXIDES (CI 77492),MAGNESIUM MYRISTATE,METHICONE,DIMETHICONE,ETHYLHEXYLGLYCERIN,IRON OXIDES (CI 77491),TRIETHOXYCAPRYLYLSILANE,GLYCERYL CAPRYLATE,FRAGRANCE(PARFUM),IRON OXIDES (CI 77499),ULTRAMARINES (CI 77007),SODIUM HYALURONATE,WATER,BUTYLENE GLYCOL,CITRUS UNSHIU FRUIT EXTRACT,PHENOXYETHANOL,PSIDIUM GUAJAVA FRUIT EXTRACT,MANGIFERA INDICA (MANGO) FRUIT EXTRACT,CITRUS PARADISI (GRAPEFRUIT) FRUIT EXTRACT,COCOS NUCIFERA (COCONUT) FRUIT EXTRACT,ACTINIDIA CHINENSIS (KIWI) FRUIT EXTRACT,CARICA PAPAYA (PAPAYA) FRUIT EXTRACT
Purpose: Sunscreen [UV Protection]
CAUTIONS: 1. For external use only. 2. Discontinue use if signs of irritation or rashes appear. 3. Keep out of reach of children 4. Replace the cap after use.
HOW TO USE: Using the puff, apply an appropriate amount to the dry skin.
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 8806173419944 | GTIN-13: 8806173419944 EAN-13: 8806173419944 GTIN storage (14 digits): 08806173419944 | moist essential pact 23 natural beige carton.jpg |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 51346-308-01 | 2021-07-05 | C162847 | 48780-1 | 9d75b9d0-4648-f424-e053-dadaa90a57ce | a7f46d6e-9d7e-4c34-a158-6fb98cc46c3f |
| 51346-308-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-4648-f424-e053-dadaa90a57ce | a7f46d6e-9d7e-4c34-a158-6fb98cc46c3f |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| OCTINOXATE | ACTIVE INGREDIENT | 4Y5P7MUD51 | 1 | |
| TITANIUM DIOXIDE | ACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| ZINC OXIDE | ACTIVE INGREDIENT | SOI2LOH54Z | 1 | |
| OCTINOXATE | ACTIVE MOIETY | 4Y5P7MUD51 | 1 | |
| TITANIUM DIOXIDE | ACTIVE MOIETY | 15FIX9V2JP | 1 | |
| ZINC CATION | ACTIVE MOIETY | 13S1S8SF37 | 1 | |
| MICA | INACTIVE INGREDIENT | V8A1AW0880 | 1 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 51346-308 | 51346-308-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| TITANIUM DIOXIDE | 15FIX9V2JP | ACTIB |
| OCTINOXATE | 4Y5P7MUD51 | ACTIB |
| ZINC OXIDE | SOI2LOH54Z | ACTIM |
| TALC | 7SEV7J4R1U | IACT |
| MICA | V8A1AW0880 | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| TALC | TALC | 7SEV7J4R1U | TABLET, DELAYED RELEASE / ORAL | 349 mg | ||
| TALC | TALC | 7SEV7J4R1U | POWDER, FOR SUSPENSION / ORAL | 735 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, CHEWABLE / ORAL | 202 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, EXTENDED RELEASE / ORAL | 300 mg | ||
| TALC | TALC | 7SEV7J4R1U | GRANULE, FOR SUSPENSION / ORAL | 296 mg | ||
| TALC | TALC | 7SEV7J4R1U | GRANULE, DELAYED RELEASE / ORAL | 525 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET / RECTAL | 32.4 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, FILM COATED / ORAL | 91 mg | ||
| TALC | TALC | 7SEV7J4R1U | POWDER / TOPICAL | 9235 mg | ||
| TALC | TALC | 7SEV7J4R1U | GRANULE / ORAL | 322 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET / SUBLINGUAL | 32.4 mg | ||
| TALC | TALC | 7SEV7J4R1U | GUM, CHEWING / BUCCAL | NA | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 357 mg | ||
| TALC | TALC | 7SEV7J4R1U | OINTMENT / TOPICAL | 74.6 %w/w | ||
| TALC | TALC | 7SEV7J4R1U | TABLET / BUCCAL | 15 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET / ORAL | 1000 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, DELAYED RELEASE PARTICLES / ORAL | 56 mg | ||
| TALC | TALC | 7SEV7J4R1U | CAPSULE, DELAYED RELEASE / ORAL | 420 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 18 mg | ||
| TALC | TALC | 7SEV7J4R1U | ELIXIR / ORAL | 4.5 mg/5ml | ||
| TALC | TALC | 7SEV7J4R1U | PELLET / ORAL | 69 mg | ||
| TALC | TALC | 7SEV7J4R1U | CAPSULE / ORAL | 729 mg | ||
| TALC | TALC | 7SEV7J4R1U | CAPSULE, COATED / ORAL | 87 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, SUGAR COATED / ORAL | NA | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, FOR SUSPENSION / ORAL | 24 mg | ||
| TALC | TALC | 7SEV7J4R1U | CAPSULE, EXTENDED RELEASE / ORAL | 5119 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, COATED / ORAL | 320.75 mg | ||
| TALC | TALC | 7SEV7J4R1U | SUSPENSION, EXTENDED RELEASE / ORAL | 46 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, ORALLY DISINTEGRATING / ORAL | 80 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 60 mg | ||
| TALC | TALC | 7SEV7J4R1U | CAPSULE, COATED, EXTENDED RELEASE / ORAL | 20 mg | ||
| TALC | TALC | 7SEV7J4R1U | DROPS / ORAL | NA | ||
| TALC | TALC | 7SEV7J4R1U | LOZENGE / ORAL | 50 mg | ||
| TALC | TALC | 7SEV7J4R1U | CAPSULE, COATED PELLETS / ORAL | 14 mg | ||
| TALC | TALC | 7SEV7J4R1U | SUSPENSION / ORAL | 234 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| d11c9b2f-2bab-4ffb-b1d6-95f3e440272e | a7f46d6e-9d7e-4c34-a158-6fb98cc46c3f | 2021-07-05 | Warnings | a7f46d6e-9d7e-4c34-a158-6fb98cc46c3f |
Adverse event summaries are temporarily unavailable. Other product information remains available.